RUBINSTEIN JULIE — SEC Form 4 filings
SEC reporting owner CIK 1780664. 17 Form 4 filings on record with FilingPulse; latest filed 2026-04-29.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-06 to 2026-04-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 51 legs across 16 filings — 1,047,982 shares, $13,922,415 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 101.
- Largest priced transaction: sale of 122,523 shares @ $13.17 ($1,613,628) in Adaptive Biotechnologies Corp, filed 2026-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | President and COO | 17 | — | 51 legs · 1,047,982 sh · $13,922,415 | 101 |
Form 4 filings — RUBINSTEIN JULIE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,707 @ $8.46 · Sale (S): 19,037 @ $14.23 · Option exercise (M): 14,707 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.13 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $13.74 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.02 · +3 more | EDGAR |
| 2026-04-21 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.57 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.55 · Option exercise (M): 14,722 @ $8.46 · Option exercise (M): 11,881 @ $12.14 · +5 more | EDGAR |
| 2026-04-16 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.56 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.61 · Option exercise (M): 14,722 @ $8.46 · Sale (S): 19,060 @ $14.18 · +3 more | EDGAR |
| 2026-04-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 16,960 @ $13.79 · Sale (S): 2,100 @ $14.44 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 18,660 @ $12.75 · Sale (S): 400 @ $13.48 · +8 more | EDGAR |
| 2026-04-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.33 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.56 · Option exercise (M): 14,722 @ $7.27 · Option exercise (M): 11,881 @ $12.14 · +6 more | EDGAR |
| 2026-04-02 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.45 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.60 · Option exercise (M): 14,722 (derivative) @ $0 · Option exercise (M): 14,722 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 2,738 @ $12.49 · Sale (S): 16,322 @ $13.48 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $12.63 · Option exercise (M): 14,722 @ $7.27 · +4 more | EDGAR |
| 2026-03-26 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $13.70 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.27 · Option exercise (M): 14,722 @ $7.27 · Sale (S): 19,060 @ $14.12 · +3 more | EDGAR |
| 2026-03-23 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.18 · Option exercise (M): 3,939 @ $6.55 · Option exercise (M): 10,783 @ $7.27 · Sale (S): 19,060 @ $13.37 · Option exercise (M): 14,722 @ $7.27 · +5 more | EDGAR |
| 2026-03-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.41 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.40 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $13.18 · +3 more | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 122,523 @ $13.17 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 19,060 @ $14.08 · Option exercise (M): 14,722 @ $6.55 · Sale (S): 13,660 @ $12.63 · Sale (S): 5,400 @ $13.43 · +5 more | EDGAR |
| 2026-03-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 30,941 @ $15.14 · Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 30,941 @ $14.79 · +9 more | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 81,250 @ $0 | EDGAR |
| 2026-03-05 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · Sale (S): 24,423 @ $15.49 · Sale (S): 6,518 @ $16.33 · Option exercise (M): 14,722 @ $6.55 · Option exercise (M): 11,881 @ $12.14 · +10 more | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 175,000 @ $0 · Sale (S): 40,044 @ $6.98 · Sale (S): 19,461 @ $6.99 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 175,000 @ $0 · Sale (S): 25,580 @ $3.43 · Sale (S): 13,490 @ $3.56 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780664 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →